Business Review Business segment reviews continued Endoscopy continued Seasonality Endoscopy financial performance Arthroscopy procedures tend to be higher in the winter months quarter Revenue one and quarter four where accidents and sports related injuries are Endoscopy revenue highest.
Conversely, elective procedures tend to slow down in the $m summer months due to holidays.
C A Arthroscopy 807 B B Visualisation 107 Market and competition C Other 25 Smith & Nephew estimates that the global arthroscopy segment the combination of repair and resection products in which the business A A principally participates is worth approximately $3.8 billion per annum and has recently been growing at approximately 8% annually.
Arthroscopy growth rates are driven by increasing numbers of sports injuries, longer and more active lifestyles, patient desire for minimally 2011 invasive procedures, innovative technological developments and a Endoscopy revenue increased by $84m, or 10%, to $939m in 2011 from need for cost-effective procedures.
The arthroscopy segment has a $855m in 2010, comprising 4% favourable currency translation and 6% particular focus on arthroscopic repair of the knee and shoulder using a underlying growth.
The Group also expects to benefit from the demand for less invasive approaches to arthroscopic hip repair.
Underlying growth in Endoscopy revenue reconciles to reported growth, the most directly comparable financial measure calculated in Management believes that Smith& Nephew has a 21% share of the accordance with IFRS, as follows: global arthroscopy segment as at 31December 2011.
Smith& Nephews main competitors were Arthrex, Mitek Johnson& Johnson, 2011 2010 Stryker, Arthrocare and Linvatec ConMed.
% % Global arthroscopy competitor share i Reported growth 10 8 Constant currency exchange effect 4 1 % A Smith & Nephew 21 Underlying growth 6 7 G A B Arthrex 25 F In the US, revenue increased by $10m to $363m in 2011 3%, all of C Mitek Johnson & Johnson 16 E which represents underlying growth.
D Stryker 11 E Linvatec ConMed 6 B Outside the US, revenue increased by $74m to $576m in 2011 15%, of D F Arthrocare 5 which 8% was underlying growth and 7% was due to favourable foreign G Others 16 C currency translation.
i Competitor shares are based on estimates for selected segments and competitors, and may not Global revenue of sports medicine repair products increased by $57m be comprehensive.
to $448m 15%, of which 10% was underlying growth and 5% favourable foreign currency translation.
The repair business benefited from launch of the FAST-FIX 360 Meniscal Repair System and BIORAPTOR CURVED guide systems during the year.
Revenue in the global resection products sector increased by $21m to $303m 7%, of which 4% represents underlying revenue growth and 3% of favourable foreign currency translation.
The resection franchise benefited from sales of the Groups new DYONICS PLATINUM range of speciality blades.
